Polygenetic risk scores and phenotypic constellations of obsessive-compulsive disorder in clozapine-treated schizophrenia.

"Declarations Conflict of interestsThe authors declare that they have no conflict of interest with regard to the content of this report. A. Hasan has received paid speakerships from Janssen, Recordati, Otsuka, and Lundbeck. He was a member of Roche, Otsuka, Lundbeck, Recordati, Rovi, and Janssen advisory boards. He is editor of the WFSBP and the German AWMF-S3 schizophrenia guidelines. Consent to participateWritten informed consent was obtained from all individual participants included in the study. Ethical standardsThe study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study. Approval was granted by the Ethics Committee of the University Hospital of Munich (LMU Munich) (Reference number 458-16) and the ethics committee of the University Medical Center Utrecht (Reference numbers 15-306/15-312). Conflict of interests The authors declare that they have no conflict of interest with regard to the content of this report. A. Hasan has received paid speakerships from Janssen, Recordati, Otsuka, and Lundbeck. He was a member of Roche, Otsuka, Lundbeck, Recordati, Rovi, and Janssen advisory boards. He is editor of the WFSBP and the German AWMF-S3 schizophrenia guidelines."

"Financial interest and funding: Open Access funding enabled and organized by Projekt DEAL. None."